Synlogic, Inc. is a biopharmaceutical company which engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. The company was founded by James J. Collins and Timothy K. Lu on December 20, 2007 and is headquartered in Winchester, MA.
Sector:
Finance
Industry:
Financial Conglomerates
Employees:
1
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Synlogic Inc market cap is $11.76M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Synlogic Inc 52 week high is $1.73 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Synlogic Inc 52 week low is $0.5401 as of November 22, 2026.
Synlogic Inc stock price today is $0.9602.
Synlogic Inc stock price yesterday was $0.9601.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Synlogic Inc's P/E ratio is -5.59.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Synlogic Inc P/B ratio is 1.1556.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Synlogic Inc 50-day moving average is $1.08.